BZ7A Stock Overview
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for BZ7A from our risk checks.
Bumrungrad Hospital Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿5.60 |
| 52 Week High | ฿7.00 |
| 52 Week Low | ฿5.40 |
| Beta | 0.21 |
| 1 Month Change | -2.61% |
| 3 Month Change | -4.27% |
| 1 Year Change | -11.81% |
| 3 Year Change | 51.35% |
| 5 Year Change | 13.98% |
| Change since IPO | 2,445.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| BZ7A | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -1.8% | 0.2% | -0.8% |
| 1Y | -11.8% | -5.5% | 1.0% |
Return vs Industry: BZ7A underperformed the German Healthcare industry which returned -5.5% over the past year.
Return vs Market: BZ7A underperformed the German Market which returned 1% over the past year.
Price Volatility
| BZ7A volatility | |
|---|---|
| BZ7A Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BZ7A has not had significant price volatility in the past 3 months.
Volatility Over Time: BZ7A's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | n/a | Artirat Charukitpipat | www.bumrungrad.com |
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics.
Bumrungrad Hospital Public Company Limited Fundamentals Summary
| BZ7A fundamental statistics | |
|---|---|
| Market cap | €4.56b |
| Earnings (TTM) | €178.73m |
| Revenue (TTM) | €651.68m |
25.5x
P/E Ratio7.0x
P/S RatioIs BZ7A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BZ7A income statement (TTM) | |
|---|---|
| Revenue | ฿25.55b |
| Cost of Revenue | ฿12.89b |
| Gross Profit | ฿12.65b |
| Other Expenses | ฿5.65b |
| Earnings | ฿7.01b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 8.81 |
| Gross Margin | 49.52% |
| Net Profit Margin | 27.43% |
| Debt/Equity Ratio | 0.1% |
How did BZ7A perform over the long term?
See historical performance and comparison